Trial intelligence / Profile preview

Fludrocortisone supplementation and fluid/electrolyte balance in very preterm infants

2016-000649-30Phase 2Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jun 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in preterm birth and hyponatraemia comparing Fludrocortisone with Placebo (2 arms). Primary endpoint: Urinary sodium/creatinine ratio at day 3. Started Jun 2016; status: completed.

02

Drugs

fludrocortisone
03

Conditions

preterm birthhyponatraemia

Beyond the preview

Go deeper on 2016-000649-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2016-000649-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call